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Abstract: Most published series of patients with focal cortical dysplasia and epilepsy are surgical or pathological series of 
pediatric cases. Patients have a high frequency of seizure. The description of clinical features and the frequency patterns of 
non-surgical adult patients are less describe. We retrospectively reviewed the clinical records of adult patients (>18 years of 
age) that visited the Epilepsy Centre of the Ramos Mejía Hospital in the city of Buenos Aires between 2010 and 2012. We 
included all cases with confirmed diagnosis of epilepsy and MRI diagnosis of focal cortical dysplasia by standardized 1.5 T 
MRI. We analyzed the following variables: sex, age at seizure onset, seizure types, seizure frequency, presence of abnormal 
neurological exam, family history of epilepsy, existence of perinatal insults and electroencephalography or video-EEG with 
at least one ictal recording. We included 20 patients since 2010–2012. Mean age of our population was 25.9 years (9–46 
years), 7 females, 13 males, they all had a negative family history of epilepsy, and only two patients had pathological 
neurological exam, both with mild contralateral paresis. Mean seizure onset age was 5.71 years (2 months–17 years) and the 
average frequency was 5.1 seizures per month (0–15). Two patients became seizure-free after adjusting antiepileptic drugs. 
Focal seizures were presented in the 100% of our population. The low frequency of seizure emphasizes the heterogeneity of 
these patients and the importance of the correct use of antiepileptic drugs schemes, as well as it can be dynamic over time. A 
proportion of medically resistant patients with cortical dysplasia are poor surgical candidates because the lesion cannot be 
completely identify or removed if it involves eloquent areas of the cortex. With the development of new drugs and the correct 
choice of treatment schedules is expected that more patients with focal cortical dysplasia would be treated successfully. 
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1. Introduction 
Malformations of cortical development (MCD) are a 
heterogeneous group of focal and diffuse cortical 
derangements whose pathological features depend largely 
on the timing of the defect in the developmental process and 
to a lesser extent on its cause [1, 2]. MCD are considered the 
second most common cause of medically resistant focal 
epilepsy in adults after hippocampal sclerosis [3]. In 
patients with resistant epilepsy, the MCD have been 
observed in 8-12% of cases [4] and in up to 14% of children 
with resistant epilepsy and mental retardation [5, 6]. 
Focal cortical dysplasia (FCD) is the most frequent type 
of MCD. They were first described by Taylor et al. in 1971 
[7] in resected tissue from epileptic patients as focal cortical 
lesions with severe cortical dyslamination, the presence of 
dysmorphic and inmature neurons throughout all but the first 
layer of the cortex, and, in most cases, cells of uncertain 
origin called “balloon cells” (BCs). FCDs are highly 
epileptogenic lesions frequently associated with a wide 
spectrum of clinical manifestations that include epilepsy, 
mental retardation and neurological deficits.  
With the improvements of genetics and the introduction of 
modern neuroimaging since the late 1980s, the detection of 
FCD in patients with resistant epilepsy has increased 
markedly. With better detection it is also becoming clear that 
FCD constitutes a wide spectrum of histopathologic and 
clinical presentations much broader than initially suspected 
[2]. This ranges from mild cortical dysplasia (currently 
termed FCD type I) presenting with difficult visualization by 
MRI, to more severe and obvious by MRI (FCD type II or III) 
presenting mostly in young children with aggressive 
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seizures and status epilepticus. 
Most published series of FCD are surgical series of 
patients with drug resistant epilepsy and a very high seizure 
frequency even daily. The aim of our work is to contribute 
to a better characterization of patients with epilepsy 
associated with FCD visible on MRI without the bias of 
being a surgical series. We emphasize the heterogeneity of 
this group of patients and that seizure frequency is not 
always as high as previously published by other authors. 
2. Material and Methods 
We retrospectively reviewed the clinical records of adult 
patients (>18 years of age) that visited the Epilepsy Centre 
of the Ramos Mejía Hospital in the city of Buenos Aires, 
between 2010 and 2012. We included all cases with 
confirmed diagnosis of epilepsy and whose MRI had 
identified FCD. A standardized 1.5T MRI that included T1- 
and T2-weighted, inversion recovery and fluid-attenuated 
inversion recovery acquisitions was used. We only included 
cases in which the opinion of two different neurologists 
(one of them specialized in imaging techniques) agreed on 
the diagnosis.  
We analyzed the following variables: sex, age, age at 
seizure onset, seizure types, seizure frequency, presence of 
abnormal neurological exam, mental retardation, family 
history of epilepsy or neurological disease (first degree 
relatives), the existence or prenatal (intrauterine) or perinatal 
insults, electroencephalography (EEG) or video-EEG (VEEG) 
with at least one ictal recording. A patient was considered 
mentally retarded when his IQ was below 70 according to 
Wechsler Adult Intelligence Scale (WAIS test) [8]. Seizures 
were classified as focal or generalized based on semiology 
according to the reports of the International League Against 
Epilepsy (ILAE) Commission on Classification and 
Terminology of 1981, 1989 and the last report published in 
2010 [9]. Cases that had missing clinical or epidemiological 
data were excluded from the study. 
The MRI scans were retrospectively and independently 
reviewed by means of conventional visual analysis by two 
experienced neuroradiologists (JP and DC) who were 
involved in our epilepsy protocol. Discrepancies between 
the reviewers led to a combined re-evaluation of the case, if 
consensus was not achieved, the patient was excluded from 
the study. The following individual MRI aspects were 
considered: (1) cortical thickening; (2) GM/WM junction 
blurring; (3) WM hypersignal on TSE-T2WI and 
FLAIR-T2WI; (4) WM hyposignal on T1WI; (5) tapering of 
WM signal changes towards the ventricle (the transmantle 
sign); (6) cortex hypersignal on T2WI; and (7) gyral/sulcal 
anomalies. Subcortical WM hyperintensity on T2WI and 
hypointensity on T1WI were subjectively judged as absent 
or present. A specific MRI diagnosis of FCD was made 
when a combination of its distinctive signs was encountered 
[10-12]. When the MRI data suggested a dysplastic lesion 
but some particular features of FCD were missing, the lesion 
was discarded. Our series did not include any pediatric 
patient (neonates or infants), for whom different imaging 
variables should be considered [11]. 
The dysplastic lesions were classified on the basis of their 
anatomical location, they were also classified as lobar 
(involving a single lobe) or multilobar when they involved at 
least two lobes. They also were classified according to their 
extension using quantitative criteria; the small lesions 
included those located deeply along or at the bottom of sulci 
[12, 13].  
To classify whether patients were responsive to treatment, 
we used the latest definition proposed by the ILAE. 
According to this definition, patients were considered to 
have drug resistant epilepsy when at least two adequate and 
tolerated antiepileptic drug (AED) schedules failed to 
achieve sustained seizure freedom [14]. Each AED was 
used at the highest tolerated dose and AED levels, available 
for the classic drugs, were measured for different purposes 
(to establish adherence, toxicity, etc.). In accordance with 
ILAE Treatment Guidelines, [15] carbamazepine is most 
often selected in our center as the first choice for adults 
with partial onset seizures. Monotherapy is always seen as 
the best alternative whenever possible, and newer drugs are 
usually used as add-on therapies.  
3. Results 
3.1. Clinical Data 
We included 20 patients since 2010–2012. Mean age of our 
population was 25.9 years (9–46 years), 7 females, 13 males, 
they all had a negative family history of epilepsy, and only 
two patients had pathological neurological exam, both with 
mild contralateral paresis. Past medical history before 
epilepsy onset was relevant in 8 patients, five had febrile 
seizures (25%), one case a perinatal infection (5%), and two 
suffered of perinatal hypoxia/anoxia (10%). Three patients 
had mild-to-severe mental retardation. Mean seizure onset 
age was 5.71 years (2 months–17 years) and the average 
frequency was 5.1 seizures per month (0–15). Two patients 
became seizure-free after adjusting antiepileptic drugs. Focal 
seizures were presented in the 100% of our population. The 
initial semiology was as follows: 7 subjects had focal clonic 
seizures, 6 patients had focal asymmetrical tonic seizures, 2 
patients had contralateral versive oculocephalic seizures, 3 
patients had dyscognitive phenomena with impairment of 
memory, speech, attention, and perception, and one patient 
had auditory phenomena as initial manifestation and another 
subject had hyperkinetic pedal movements. All patients 
presented a single seizure type. Seven patients (35%) had 
secondarily generalized seizures. In the two cases of seizure 
free, clinical semiology was assumed taking account that the 
story of the patient and family members committed to their 
care match. None of our patients had history of status 
epilepticus, epilepsy partialis continua, reflex seizures or 
history of infantile spams (Table 1).  
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Table 1. Mean clinical features 
Patient Age (years) Onset sz (years) Personal history Sz/month MRI (FCD) Initial sz semiology 
1 15 5 No 5/month 
Left frontal - medial aspect of 
superior gyrus 
Tonic elevation R arm 
2 32 4 Prolonged labor 4/month 
Left frontal - medial aspect of 
superior gyrus 
Tonic posture of R arm 
3 26 2 Febril seizure 5/month Left Parahippocampus Auditory phenomena 
4 30 10 Febril seizure 6/month 
Right temporal - anterior 
middle gyrus 
mnemonic (deja vu) and dyscognitive 
phenomena 
5 29 9 No 3/month Right frontal - medial gyrus Clonic of L arm 
6 27 4 No 4/month 
Right frontal (transmantle) - 
superior and middle gyrus 
Hyperkinetic pedal movements 
7 23 4 No 10/month 
Right frontal (transmantle) 
perirolandic 
Clonic of L arm 
8 23 4 Febril seizure 6/month 
Left fronto parietal 
(transmantle) 
Somatosensory (tingling) phenomena 
of R arm 
9 31 6 months Perinatal infection 2/month Right temporo-occipital 
mnemonic (deja vu) and dyscognitive 
phenomena 
10 33 16 No 4/month 
Right frontal (transmantle) 
middle gyrus 
Tonic posture of L arm 
11 5 5 months Hypoxia 15/month Right frontal anterior Clonic of L arm 
12 19 3 Hypoxia 8/month Left parietal Tonic posture of R arm 
13 19 14 No 3/month 
Right frontal (transmantle) - 
superior gyrus 
L oculocephalic versive sz 
14 15 9 months Febril seizure Seizure free Right parietal + Right HS 
mnemonic (deja vu) and dyscognitive 
phenomena 
15 46 17 No Seizure free Right frontal - middle gyrus L hemiclonic movements 
16 5 5 No 3/month Right frontal - middle gyrus 
Clonic of L arm with jacksonian 
march 
17 23 3 No 14/month Right frontal anterior Tonic elevation of L arm 
18 29 1 Febril seizure 4/month Left frontal middle gyrus Clonic of R arm 
19 12 11 No 3/month Right frontal middle gyrus Tonic posture of L arm 
20 9 2 months No 3/month 
Right parietal + Left frontal 
cavernoma 
L oculocephalic versive sz 
L: left, R: right, sz: seizure 
 
Figure 1. Right precentral focal cortical dysplasia (A) FLAIR coronal view 
and (B) T1 axial view. 
3.2. MRI 
The frontal lobe was affected in 14 cases (70%) (Fig. 1). In 
10 cases (50%) the dysplastic cortex was located on the medial 
aspect of the brain, and there were no cases affecting both the 
medial and the lateral surfaces. Three cases involve at least two 
lobes. Five cases (25%) have transmantle characteristics, all of 
them involving the frontal lobe (Table 1). 
3.3. Response to Treatment and Epilepsy Surgery 
According to the definition proposed by the ILAE [14] 
all patients, except two subjects had drug resistant epilepsy. 
The resistant cases failed to achieve sustained seizure 
freedom with at least two adequate and tolerated AED 
schedules. With the current scheme of treatment, patients 
have decreased seizure frequency by more than 50% and in 
two patients (10%) achieved complete seizure control only 
with AEDs, one patient in monotherapy with CBZ and the 
other with polytherapy with three drugs (VPA, LTG and 
CNZ). All patients, except two, were on polytherapy, eight 
(40%) having tried 3 or more AEDs in different 
combinations. The most used AED was CBZ in thirteen 
patients (65%) (Table 2). 
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Table 2. AEDs schedules 
Patient Sz Frequency AEDs 
1 5/month CBZ CNZ 
2 4/month CBZ TPM 
3 5/month VPA LTG CNZ 
4 6/month CBZ TPM FB 
5 3/month CBZ 
6 4/month OXC VPA CNZ 
7 10/month CBZ FB 
8 6/month CBZ TPM 
9 2/month VPA TPM CLB 
10 4/month CBZ LVT 
11 15/month CBZ TPM 
12 8/month VPA LTG CNZ 
13 3/month OXC TPM 
14 sz free VPA LTG CNZ 
15 sz free CBZ 
16 3/month VPA CNZ 
17 14/month CBZ TPM 
18 4/month CBZ CNZ 
19 3/month CBZ DZP TPM FB DFH 
20 3/month CBZ LVT CNZ 
CBZ: carbamacepine, CNZ: clonazepam, FB: phenobarbital, LTG: 
lamotrigine, LVT: levetiracetam, OXC: oxcarbacepine, TPM: topiramate, 
VPA: valproic acid, sz: seizure 
4. Conclusions 
Our series of 20 patients with MRI diagnosis of FCD is 
heterogeneous, with different locations and different 
response to AEDs.  
Almost all patients began their seizure at early childhood. 
All patients presented focal seizures with clinical semiology 
concordant with lesional area seen on MRI. Most of them 
have FCD in the frontal lobe. As mentioned by other authors 
[5,6,22,26], FCD is associated with a wide range of clinical 
presentations. There is no particular seizure semiology that 
characterizes patients with FCD compared with other 
surgical series of epilepsy patients [16-18]. There are no 
distinctive interictal or ictal scalp EEG features that are 
exclusively associated with FCD. The EEG can show 
interictal background slowing, interictal spikes and 
polyspikes, and ictal events with electrographic 
characteristics similar to other patients with intractable 
epilepsy who are undergoing presurgical evaluation [19-21]. 
All patients, except two who became seizures free, have 
drug-resistant epilepsy according ILAE definition [14]. 
However, the average low frequency of seizures and no 
cases of status epilepticus (SE), epilepsia partialis continua 
(EPC), infantile spasms and reflex seizures, as referred by 
most series [16, 17] reinforces the heterogeneity of these 
pathology associated to focal epilepsy.  
Most published series of patients are surgical or 
pathological series of pediatric cases [17, 22-26]. Patients 
have a high frequency of seizure, including several in the day. 
Some reports mention EPC [27, 28] or SE [29]. 
One possible explanation for these findings, including the 
two free seizure patients, may be a different selection criterion, 
since most of the published series are surgical [16, 17]. 
This finding emphasizes the heterogeneity of these 
patients and the importance of the correct use of 
antiepileptic drugs schemes, as well as it can be dynamic 
over time. 
A proportion of medically resistant patients with cortical 
dysplasia are poor surgical candidates because the lesion 
cannot be completely identify or removed if it involves 
eloquent areas of the cortex. With the development of new 
drugs and the correct choice of treatment schedules is 
expected that more patients with cortical dysplasia would be 
treated successfully without increasing the risk of a surgery. 
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